I’ve been trying to get caught up on some reading this month, and thought I’d put together a roundup of interesting articles I’ve run across recently. Grading GDUFA, at Contract…
Although peptides were long passed over for drug development, recent technological advances have prompted the pharmaceutical industry to take a closer look at them. The increased sensitivity, resolution and throughput…
Neuland recently conducted its first annual Open Quiz and ScienceTechBiz Quiz for students in Hyderabad, held at the Bhaskara auditorium. It was an opportunity for us to do something we’re passionate…
With potential projected losses of $16-32 billion for drugs going off-patent in 2015, intellectual property (IP) is increasingly crucial to keeping a competitive edge in the pharmaceutical and biotechnology markets….
